Results

Total Results: 276 records

Showing results for "pulmonary".

41. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/v1-breast-cancer-medications-for-risk-reduction--s
    July 08, 2002 - evidence that tamoxifen and raloxifene increase the risk for thromboembolic events (for example, stroke, pulmonary … chemoprevention if they are younger; have no predisposition to thromboembolic events such as stroke, pulmonary … cancers (8 per 1,000) as the number of serious thromboembolic complications caused (1 stroke and 1 to 2 pulmonary … Increased the rate of pulmonary embolism from 0.3 cases/1,000 women in the placebo group to 1.0 cases … endometrial cancer caused, n § 1-2 12 21 "22" Strokes caused, n § 1 3 9 20 Pulmonary

42. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2002
    July 08, 2002 - evidence that tamoxifen and raloxifene increase the risk for thromboembolic events (for example, stroke, pulmonary … chemoprevention if they are younger; have no predisposition to thromboembolic events such as stroke, pulmonary … cancers (8 per 1,000) as the number of serious thromboembolic complications caused (1 stroke and 1 to 2 pulmonary … Increased the rate of pulmonary embolism from 0.3 cases/1,000 women in the placebo group to 1.0 cases … endometrial cancer caused, n § 1-2 12 21 "22" Strokes caused, n § 1 3 9 20 Pulmonary

43. Chemoprevention of Breast Cancer - Recommendations and Rationale (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/MnkNvteY4Yg_8Jut4SayVN
    July 02, 2002 - evidence that tamoxifen and raloxifene increase the risk for thromboembolic events (for example, stroke, pulmonary … chemoprevention if they are younger; have no predisposition to thromboembolic events such as stroke, pulmonary … cancers (8 per 1,000) as the number of serious thromboembolic complications caused (1 stroke and 1 to 2 pulmonary … group to 2.2 cases/1,000 women in the study group (RR, 1.75; 95% CI, 0.98-3.20); increased the rate of pulmonary … tamoxifen therapy Cases of endometrial cancer caused, n§ 1-2 12 21 22 Strokes caused, n§ 1 3 9 20 Pulmonary

44. Evidence Summary: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
    May 02, 2023 - That trial enrolled participants with pulmonary fibrotic lesions, a group thought to be at the highest … The evaluation of the Quantiferon-TB Gold test in pulmonary and extrapulmonary tuberculosis. … Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis … TB assay results in patients with pulmonary and extra-pulmonary TB. … Characteristics of IFN-γ responses in IGRA among pulmonary TB suspects in a TB-endemic area.

45. Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening
    September 06, 2016 - A randomized clinical trial (RCT) of 24 weeks of isoniazid in individuals with pulmonary fibrotic lesions … Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis. … The evaluation of the Quantiferon-TB Gold test in pulmonary and extrapulmonary tuberculosis. … Characteristics of IFN-γ responses in IGRA among pulmonary TB suspects in a TB-endemic area. … g Fibrotic pulmonary lesions defined as well-delineated radiographic lesions of probable tuberculous

46. Archived: Evidence Summary: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-latent-tuberculosis/latent-tuberculosis-infection-screening-september-2016
    September 06, 2016 - A randomized clinical trial (RCT) of 24 weeks of isoniazid in individuals with pulmonary fibrotic lesions … Usefulness of the QuantiFERON TB-2G test for the differential diagnosis of pulmonary tuberculosis. … The evaluation of the Quantiferon-TB Gold test in pulmonary and extrapulmonary tuberculosis. … Characteristics of IFN-γ responses in IGRA among pulmonary TB suspects in a TB-endemic area. … g Fibrotic pulmonary lesions defined as well-delineated radiographic lesions of probable tuberculous

47. Announcements | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=5
    January 13, 2022 - Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Chronic Obstructive Pulmonary

48. Screening for Lung Cancer: Clinical Summary of USPSTF Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/sN6DG_LdfFyf98hhVQjetB
    December 23, 2013 - risk factors include specific occupational exposures, radon exposure, family history, and history of pulmonary

49. Archived: Lung Cancer: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening-1996
    January 01, 1996 - Suboptimal technique, insufficient exposure, and poor positioning and cooperation of the patient can obscure pulmonary … disagreements were considered potentially significant. 4 Most errors are false-negative interpretations, and pulmonary … only at the beginning and end of the trial. 14 Similar findings were reported in the Philadelphia Pulmonary … Occupational medicine state of the art review: prevention of pulmonary disease.

50. Announcements | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=8
    January 07, 2021 - for Colorectal Cancer 2020-10-27 Final Research Plan: Screening for Chronic Obstructive Pulmonary

51. Update Existing Topic | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/public-comments-and-nominations/nominating-recommendation-statement-topics/update-an-existing-prevention-recommendation
    March 30, 2025 - Child Maltreatment: Primary Care Interventions Chlamydia and Gonorrhea: Screening Chronic Obstructive Pulmonary

52. Announcements | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=24
    September 25, 2014 - Acuity in Older Adults 2014-06-12 Final Research Plan: Screening for Chronic Obstructive Pulmonary

53. Announcements | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=9
    July 30, 2020 - Cancer 2020-07-07 Public Comment on Draft Research Plan: Screening for Chronic Obstructive Pulmonary

54. Archived: Lung Cancer: Screening, May 2004 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening-2004
    May 15, 2004 - major risk factor for lung cancer, 6 other risk factors include family history, chronic obstructive pulmonary … disease, idiopathic pulmonary fibrosis, environmental radon exposure, passive smoking, asbestos exposure … of false-positive results is likely to be because of underlying differences, such as prevalence of pulmonary … Textbook of pulmonary diseases, 6th ed . Philadelphia, PA: Lippincott-Raven Publishers; 1998.

55. Screening for Skin Cancer (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/XJDNVYtZUo-CJJcsWum98D
    October 12, 2012 - such as stroke, invasive breast cancer, dementia, gallbladder disease, deep venous thrombosis, and pulmonary

56. Announcements | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=20
    April 28, 2016 - Task Force 2016-04-07 Final Recommendation Statement: Screening for Chronic Obstructive Pulmonary

57. Announcements | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=22
    August 18, 2015 - Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Chronic Obstructive Pulmonary

58. Announcements | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=25
    May 27, 2014 - Cancer 2014-02-25 Public Comment on Draft Research Plan: Screening for Chronic Obstructive Pulmonary

59. Draft Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/aspirin-use-to-prevent-preeclampsia-and-related-morbidity-and-mortality-preventive-medication1
    June 20, 2019 - cerebrovascular disorder, cerebrovascular hemorrhage, edema, or embolus Renal or hepatic injury/failure Pulmonary

60. U.S. Preventive Services Task Force Issues Draft Recommendation Statement on Screening for COPD (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/copd-screening-draft-rec-bulletin.pdf
    December 06, 2021 - Force (Task Force) today posted a draft recommendation statement on screening for chronic obstructive pulmonary